PDF下载 ( 175 KB)
-
摘要: <正> 肝细胞癌(HCC)是最常见的原发性肝肿瘤,居世界癌的第四位。估计全世界新病例每年超过500000。在高发区主要影响男性,男:女为3:2。东南亚、非洲亚撒哈拉和阿拉斯加(Alaska)为高发地区。据美国统计1970年HCC发病率为1.4/100000人,1990年增加到2.4/100000人。且此增加与丙肝、肥胖流行率增加相平行。了解HCC的易感状态和癌前病变有助于HCC的诊断和加强HCC的防治。
-
为使作者了解我刊的编辑出版计划，及时地为我刊惠赐稿件，《临床肝胆病杂志》编委会确定了2021年1-9期“重点号”选题及各期执行主编：
1期 肝硬化的系统和综合治疗·······························································贾继东
2期 肝癌肝移植的研究进展···································································朱继业
3期 肝肿瘤的消融治疗···········································································李 肖
4期 肝衰竭相关并发症的临床诊疗······················································谢 青
5期 抗HBV新药研发与临床研究进展·················································张晓东
6期 非酒精性脂肪性肝炎新药研发与临床研究进展························施军平
7期 慢性病毒性肝炎重叠脂肪肝························································赵景民
8期 肝癌临床诊疗新实践·····································································陈东风
9期 中医药治疗肝癌的研究进展························································李秀惠
为本刊重点号的投稿请注明“***重点号投稿”字样。
对于围绕重点号选题的文章，本刊将择优优先发表。欢迎广大作者踊跃投稿。
《临床肝胆病杂志》编辑部
2021年2月20日
-
本文二维码
计量
- 文章访问数: 2165
- HTML全文浏览量: 14
- PDF下载量: 741
- 被引次数: 0
下载:
